Table 4.

Associations between variables collected at patient's last visit and current disease activity

Variables	Active disease		Inactive disease
	OR (95% CI)	p Value	OR (95% CI)	p Value
Age of disease onset*	1.0 (0.9 to 1.0)	0.186	1.0 (1.0 to 1.1)	0.186
Disease duration*	1.1 (1.0 to 1.1)	<0.001†	1.0 (0.9 to 1.0)	<0.001†
Delay in diagnosis*	1.1 (1.0 to 1.1)	0.017†	0.9 (0.9 to 0.9)	0.017†
ANA*	0.9 (0.4 to 1.8)	0.682	1.2 (0.5 to 2.5)	0.682
RF*	1.5 (0.5 to 4.2)	0.472	0.7 (0.2 to 2.0)	0.475
B27*	1.5 (0.5 to 5.1)	0.481	0.6 (0.2 to 2.2)	0.481
ACPA*	2.5 (0.5 to 11.8)	0.239	0.4 (0.1 to 1.8)	0.239
Years of education*	1.0 (0.9 to 1.1)	0.686	1.0 (0.9 to 1.1)	0.686
Professional activity*‡
Unemployed	0.6 (0.2 to 1.9)	0.352	1.8 (0.5 to 5.8)	0.352
Retired	NA	NA	NA	NA
Retired due to JIA disability	3.0 (0.8 to 1.9)	0.118	0.3 (0.1 to 1.3)	0.118
HAQ score*	9.1 (4.1 to 20.2)	<0.001†	0.1 (0.1 to 0.2)	<0.001†
Duration of corticosteroid therapy*	1.0 (1.0 to 1.0)	0.019†	1.0 (1.0 to 1.0)	0.019†
Exposure to corticosteroids*	1.6 (0.9 to 2.9)	0.077	0.6 (0.3 to 1.1)	0.077
Exposure to biological DMARDs*	1.3 (0.7 to 2.2)	0.375	0.8 (0.4 to 1.4)	0.375
Exposure to synthetic DMARDs*	0.8 (0.4 to 1.6)	0.552	1.2 (0.6 to 2.4)	0.552

†p Value<0.05.

*Adjusted for ILAR Category.

‡Compared to employed.

ACPA, anticitrullinated protein antibodies; ANAs, antinuclear antibodies; AS, ankylosing spondylitis; ASD, adult Still disease; DMARDs, disease-modifying antirheumatic drugs; E. oligoarthritis, extended oligoarthritis; EA, enteropathic arthritis; ERA, enthesitis-related arthritis; ILAR, International League of Associations for Rheumatology; JIA, juvenile idiopathic arthritis; PsA, psoriatic arthritis; RA, rheumatoid arthritis; RF, rheumatoid factor; RF+ polyarthritis, rheumatoid factor negative polyarthritis; RF+ polyarthritis, rheumatoid factor positive polyarthritis; SoJIA, systemic-onset juvenile idiopathic arthritis; Undif. arthritis, undifferentiated arthritis; USpA, undifferentiated spondyloarthritis.